Oncology Impact Fund (Cayman) Management L.P., 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 75,070 shares at $18.70 ($1.4M) on 2021-04-20, disclosed to the SEC on 2021-04-20.
Open-market sale of $1.4M HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.82 | 5,547 | $110K | 7.7% |
| 2 | $19.82 | 5,547 | $110K | 7.7% |
| 3 | $20.56 | 300 | $6K | 0.4% |
| 4 | $19.29 | 9,956 | $192K | 13.4% |
| 5 | $19.29 | 9,956 | $192K | 13.4% |
| 6 | $20.08 | 100 |
| $2K |
| 0.1% |
| 7 | $18.70 | 21,415 | $400K | 28.0% |
| 8 | $18.70 | 21,415 | $400K | 28.0% |
| 9 | $19.09 | 834 | $16K | 1.1% |
| Total | $19.04 avg | 75,070 | $1.4M | 100% |
| Filing → |
| ITOS | SELL | 2021-11-24 | $8.9M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |